Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term

Unlike other drugs of abuse such as alcohol, nicotine, opiates/opioids, the FDA has not approved any agent to treat psychostimulant dependence. Certainly, it is widely acceptable that dopaminergic signaling is a key factor in both the initiation and continued motivation to abuse this class of stimul...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Kenneth, Badgaiyan, Rajendra D., Braverman, Eric R., Dushaj, Kristina, Li, Mona, Thanos, Peter K., Demetrovics, Zsolt, Febo, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351297/
https://www.ncbi.nlm.nih.gov/pubmed/28317038
http://dx.doi.org/10.17756/jrdsas.2016-023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351297/
https://www.ncbi.nlm.nih.gov/pubmed/28317038
http://dx.doi.org/10.17756/jrdsas.2016-023

Ejemplares similares